Growth Metrics

Merck (MRK) Net Margin Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -2,996.00
Dec 31, 2025 1,328.00
Sep 30, 2025 2,785.00
Jun 30, 2025 2,095.00
Mar 31, 2025 605.00
Dec 31, 2024 6,754.00
Sep 30, 2024 359.00
Jun 30, 2024 1,141.00
Mar 31, 2024 376.00
Dec 31, 2023 -2,455.00
Sep 30, 2023 1,162.00
Jun 30, 2023 -5,589.00
Mar 31, 2023 1,212.00
Dec 31, 2021 534.00
Jun 30, 2021 -937.00
Mar 31, 2021 -802.00
Dec 31, 2020 -484.00
Sep 30, 2020 -1,253.00
Jun 30, 2020 4.00
Mar 31, 2020 1,653.00
Dec 31, 2019 -11,348.00
Sep 30, 2019 741.00
Jun 30, 2019 389.00
Mar 31, 2019 960.00
Dec 31, 2018 897.00
Sep 30, 2018 772.00
Jun 30, 2018 791.00
Mar 31, 2018 -776.00
Dec 31, 2017 278.00
Sep 30, 2017 -1,584.00
Jun 30, 2017 486.00
Mar 31, 2017 143.00
Dec 31, 2016 138.00
Sep 30, 2016 643.00
Jun 30, 2016 -462.00
Mar 31, 2016 2,409.00
Dec 31, 2015 4,337.00
Sep 30, 2015 3,691.00
Jun 30, 2015 2,161.00
Mar 31, 2015 2,860.00
Dec 31, 2014 -3,929.00
Sep 30, 2014 9.00
Jun 30, 2014 786.00
Mar 31, 2014 196.00